CAMP4 Therapeutics Corpor...
(CAMP)
undefined
undefined%
At close: undefined
7.63
-4.03%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients.
The company was founded by Richard A.
Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
CAMP4 Therapeutics Corporation
| Country | United States |
| IPO Date | Oct 11, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 58 |
| CEO | Joshua Mandel-Brehm |
Contact Details
Address: One Kendall Square Bldg 1400 West, 3rd Floor Cambridge, Massachusetts United States | |
| Website | https://www.camp4tx.com/ |
Stock Details
| Ticker Symbol | CAMP |
| Exchange | NASDAQ |
| Fiscal Year | March - February |
| Reporting Currency | USD |
| CIK Code | 0000730255 |
| CUSIP Number | 13463J101 |
| ISIN Number | US13463J1016 |
| Employer ID | 95-3647070 |
| SIC Code | 3663 |
Key Executives
| Name | Position |
|---|---|
| Joshua Mandel-Brehm | Chief Executive Officer, President & Director |
| Kelly Gold | Chief Financial Officer |
| Michelle Gates | Senior Vice President & Chief People Officer |
| Caleb Moore | Chief Business Operations Officer & SVice President of Portfolio Strategy & Business Operations |
| Dr. Daniel Tardiff Ph.D. | Vice President & Head of Discovery |
| Dr. David Bumcrot Ph.D. | Chief Scientific Officer & Senior Vice President of Research |
| Dr. Leonard I. Zon M.D. | Founder |
| Dr. Richard A. Young Ph.D. | Founder & Independent Director |
| Dr. Satya Kuchimanchi Ph.D. | Senior Vice President of Technical Operations |
| Dr. Yuri Maricich M.B.A., M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 01, 2024 | 15-12G | Filing |
| Aug 01, 2024 | 8-K | Current Report |
| Jul 18, 2024 | S-8 POS | Filing |
| Jul 18, 2024 | S-8 POS | Filing |
| Jul 18, 2024 | S-8 POS | Filing |
| Jul 18, 2024 | S-8 POS | Filing |
| Jul 18, 2024 | S-8 POS | Filing |
| Jul 18, 2024 | S-8 POS | Filing |
| Jul 18, 2024 | S-8 POS | Filing |
| Jul 18, 2024 | S-8 POS | Filing |